MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience Total Non Current Liabilities 2011-2026 | HBIO
Annual Total Non Current Liabilities Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 58.5 M | 57.9 M | 64.4 M | 14.4 M | 21 M | 23.2 M | 22.3 M | 24.9 M | 19.4 M | 21.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.4 M | 14.4 M | 32.8 M |
Total Non Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
7.05 B | $ 19.94 | 1.06 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
66.7 M | $ 149.15 | -0.59 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
239 K | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
35.8 M | $ 2.76 | -1.08 % | $ 205 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 8.74 | 4.14 % | $ 176 M | USA |
 |
Alcon
ALC
|
6.05 B | $ 80.81 | -0.39 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
261 M | $ 36.51 | -1.19 % | $ 1.71 B | USA |
 |
Haemonetics Corporation
HAE
|
405 M | $ 66.12 | 0.23 % | $ 3.33 B | USA |
 |
electroCore
ECOR
|
1.42 M | $ 6.56 | -7.61 % | $ 36.2 K | USA |
 |
AngioDynamics
ANGO
|
148 M | $ 10.33 | 3.51 % | $ 422 M | USA |
 |
InfuSystem Holdings
INFU
|
35 M | $ 8.25 | 2.61 % | $ 170 M | USA |
 |
STERIS plc
STE
|
1.53 B | $ 261.51 | -0.05 % | $ 25.8 B | USA |
 |
The Cooper Companies
COO
|
1.54 B | $ 80.56 | 0.24 % | $ 16 B | USA |
 |
Masimo Corporation
MASI
|
56 M | $ 135.1 | -0.85 % | $ 7.2 B | USA |
 |
Glaukos Corporation
GKOS
|
87.4 M | $ 118.29 | -0.56 % | $ 5.73 B | USA |
 |
Merit Medical Systems
MMSI
|
626 M | $ 81.27 | 1.28 % | $ 4.73 B | USA |
 |
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
119 M | $ 152.4 | 2.29 % | $ 4.75 B | USA |
 |
LeMaitre Vascular
LMAT
|
19.3 M | $ 84.52 | 0.79 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
418 M | $ 503.25 | -0.85 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
917 K | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
5.25 M | $ 61.3 | -0.57 % | $ 222 M | USA |
 |
Microbot Medical
MBOT
|
760 K | $ 1.82 | -2.16 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
1.61 M | $ 4.31 | -1.82 % | $ 44.8 M | USA |
 |
Milestone Scientific
MLSS
|
1.4 M | $ 0.3 | -0.5 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.91 B | $ 23.05 | -1.45 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
9.93 M | $ 39.41 | 0.01 % | $ 130 M | USA |
 |
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
6.72 M | $ 13.67 | 0.37 % | $ 657 M | USA |
 |
Becton, Dickinson and Company
BDX
|
25 B | $ 202.08 | 0.49 % | $ 58.1 B | USA |
 |
Repligen Corporation
RGEN
|
701 M | $ 150.45 | -3.79 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
1.05 B | $ 252.03 | -2.17 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
41.7 M | $ 22.01 | -2.52 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
1.65 M | $ 2.25 | -3.43 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
2.38 M | $ 0.69 | 0.36 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
12.5 M | $ 18.85 | -0.48 % | $ 926 M | USA |
 |
Teleflex Incorporated
TFX
|
2.77 B | $ 104.3 | -1.12 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
427 M | $ 228.04 | -1.98 % | $ 16.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 12.36 | 0.73 % | $ 2.51 B | USA |